Brainstorm Cell Therapeutics reported $11.76M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Biogen USD 3B 350.5M Mar/2026
Brainstorm Cell Therapeutics USD 11.76M 757K Mar/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 199.18M 3.27M Mar/2026
Gilead Sciences USD 9.48B 2.34B Mar/2026
Grifols EUR 2.37B 156.97M Dec/2025
Halozyme Therapeutics USD 363.21M 186.12M Mar/2026
Mesoblast USD 128.07M 25.44M Dec/2025